Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study.
OBJECTIVE
Intrahepatic and extrahepatic cholangiocarcinomas are rare and highly malignant cancers of the bile duct. Although the incidence of extrahepatic cholangiocarcinoma (ECC) has remained constant, the incidence of intrahepatic cholangiocarcinoma (ICC) has increased in the United States. Because the etiology of both tumors is poorly understood, a population-based case-control study was conducted to examine the association of ECC and ICC with preexisting medical conditions.


METHODS
Medical conditions among 535 ICC patients, 549 ECC patients (diagnosed 1993-1999), and 102,782 cancer-free controls were identified by using the Surveillance, Epidemiology and End Results-Medicare databases. Logistic regression analysis was used to calculate adjusted odds ratios.


RESULTS
In addition to established risk factors (choledochal cysts, cholangitis, inflammatory bowel disease), several other conditions were significantly associated with ECC and ICC: biliary cirrhosis (ECC, ICC: P < .001), cholelithiasis (ECC, ICC: P < .001), alcoholic liver disease (ECC, P < .001; ICC, P = .01), nonspecific cirrhosis (ECC, ICC: P < .001), diabetes (ECC, ICC: P < .001), thyrotoxicosis (ECC, P = .006; ICC, P = .04), and chronic pancreatitis (ECC, ICC: P < .001). Conditions only associated with ICC were obesity (ECC, P = .71; ICC, P = .01), chronic nonalcoholic liver disease (ECC, P = .08; ICC, P = .02), HCV infection (ECC, P = .67; ICC, P = .01), and smoking (ECC, P = .07; ICC, P = .04).


CONCLUSIONS
Several novel associations with ECC and ICC were identified. HCV infection, chronic nonalcoholic liver disease, and obesity, all of which are increasing in incidence, and smoking were associated only with ICC, suggesting that these conditions might explain the divergent incidence trends of the tumors.
Welzel
Tania M
TM
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA.
Graubard
Barry I
BI
El-Serag
Hashem B
HB
Shaib
Yasser H
YH
Hsing
Ann W
AW
Davila
Jessica A
JA
McGlynn
Katherine A
KA
D000368:Aged; D001650:Bile Duct Neoplasms / Q000453:epidemiology*; D017734:Bile Ducts, Extrahepatic; D001653:Bile Ducts, Intrahepatic; D018281:Cholangiocarcinoma / Q000453:epidemiology*; D005260:Female; D006801:Humans; D015994:Incidence; D008297:Male; D011159:Population Surveillance; D012189:Retrospective Studies; D012307:Risk Factors; D018426:SEER Program / Q000706:statistics & numerical data*; D015996:Survival Rate; D014481:United States / Q000453:epidemiology
Hepatology. 2000 Jan;31(1):7-11
10613720
N Engl J Med. 2002 Apr 18;346(16):1221-31
11961152
Dig Dis Sci. 2000 Jul;45(7):1405-12
10961722
Clin Liver Dis. 2001 Feb;5(1):191-218
11218916
Chin Med J (Engl). 1998 Dec;111(12):1068-70
11263365
Alcohol Clin Exp Res. 2001 May;25(5 Suppl ISBRA):8S-14S
11391044
Soz Praventivmed. 2001;46(3):182-5
11565447
Hepatology. 2001 Oct;34(4 Pt 1):738-44
11584370
Cancer Causes Control. 2001 Dec;12(10):959-64
11808716
Hepatology. 2002 Mar;35(3):635-8
11870378
J Hepatol. 2002 May;36(5):586-9
11983440
Med Care. 2002 Aug;40(8 Suppl):IV-3-18
12187163
Cancer. 2002 Nov 1;95(9):1946-53
12404289
Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15584-9
12438687
Gastroenterology. 2003 Aug;125(2):437-43
12891546
Clin Liver Dis. 2003 Nov;7(4):779-94
14594131
J Hepatol. 2003 Dec;39(6):1042-8
14642624
J Hepatol. 2003 Dec;39(6):1049-55
14642625
Lancet. 2003 Dec 6;362(9399):1907-17
14667750
Gastroenterology. 2004 Feb;126(2):586-97
14762795
N Engl J Med. 1993 Jun 24;328(25):1797-801
7684822
Lancet. 1993 Nov 20;342(8882):1262-5
7901583
World J Surg. 1995 Jul-Aug;19(4):637-41
7676713
Hepatology. 2004 Dec;40(6):1387-95
15565570
Hepatobiliary Pancreat Dis Int. 2005 Feb;4(1):71-4
15730924
Best Pract Res Clin Gastroenterol. 2005 Feb;19(1):3-23
15757802
Gastroenterology. 2005 Mar;128(3):620-6
15765398
Gastroenterology. 2005 May;128(6):1655-67
15887157
Lancet. 2005 Oct 8;366(9493):1303-14
16214602
Cell Prolif. 2005 Dec;38(6):407-21
16300653
Gastroenterology. 2005 Dec;129(6):1937-43
16344062
Rev Gastroenterol Disord. 2005 Fall;5(4):206-14
16369216
Hepatology. 2006 Feb;43(2 Suppl 1):S99-S112
16447287
J Exp Biol. 2006 Mar;209(Pt 5):817-25
16481571
Semin Liver Dis. 2006 Feb;26(1):3-21
16496229
Semin Liver Dis. 2006 Feb;26(1):22-30
16496230
Semin Liver Dis. 2006 Feb;26(1):42-51
16496232
Dig Dis. 2005;23(3-4):241-6
16508288
Ann Hepatol. 2006 Jan-Mar;5(1):30-3
16531962
Indian J Pediatr. 2006 Mar;73(3):233-5
16567920
JAMA. 2006 Apr 5;295(13):1549-55
16595758
World J Gastroenterol. 2006 Apr 14;12(14):2181-6
16610018
J Hepatol. 2006 May;44(5):1005-8
16551483
Gastroenterology. 2006 May;130(6):1636-42
16697727
Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1198-203
16775181
J Natl Cancer Inst. 2006 Jun 21;98(12):873-5
16788161
Oncogene. 2006 Jun 26;25(27):3818-22
16799623
Cell Immunol. 2006 Jan;239(1):1-13
16765923
Int J Cancer. 2007 Feb 1;120(3):638-41
17109384
Cancer. 2000 Jun 1;88(11):2471-7
10861422